| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $192,019 | 3 | 100 |
Sells | $0 | 0 | 0 |
| Heshmatpour Amir F | President | 2 | $184,660 | 0 | $0 | $184,660 |
| Neman-Ebrahim Yousha | Chief Clinical Officer | 1 | $7,359 | 0 | $0 | $7,359 |
NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company. It develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company was founded in 2008 and is headquartered in Calabasas, CA.
Over the last 12 months, insiders at Neonc Technologies Holdings, Inc. have bought $192,019 and sold $0 worth of Neonc Technologies Holdings, Inc. stock.
On average, over the past 5 years, insiders at Neonc Technologies Holdings, Inc. have bought $199,954 and sold $3.82M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Heshmatpour Amir F (President) — $184,660. Neman-Ebrahim Yousha (Chief Clinical Officer) — $7,359.
The last purchase of 6,000 shares for transaction amount of $39,060 was made by Heshmatpour Amir F (President) on 2025‑11‑24.
| 2025-11-24 | Heshmatpour Amir F | President | 6,000 0.0221% | $6.51 | $39,060 | -31.35% | ||
| 2025-11-21 | Heshmatpour Amir F | President | 24,000 0.0822% | $6.07 | $145,600 | -14.16% | ||
| 2025-11-20 | Neman-Ebrahim Yousha | Chief Clinical Officer | 1,100 0.0042% | $6.69 | $7,359 | -14.50% | ||
| 2025-05-23 | Heshmatpour Amir F | President | 2,000 0.0083% | $7.39 | $14,785 | +10.53% | ||
| 2025-05-22 | CHEN THOMAS C | CEO | 2,709 0.0113% | $7.38 | $20,000 | +8.59% | ||
| 2025-05-22 | GARNETT KEITHLY | CFO | 675 0.0028% | $7.29 | $4,921 | +8.59% | ||
| 2025-05-21 | CHEN THOMAS C | CEO | 2,759 0.0113% | $7.25 | $20,002 | +10.86% | ||
| 2025-05-19 | GARNETT KEITHLY | CFO | 135 0.0006% | $7.23 | $976 | +7.13% | ||
| 2025-05-16 | Heshmatpour Amir F | President | 3,510 0.0334% | $16.87 | $59,221 | +6.54% | ||
| 2025-05-15 | Heshmatpour Amir F | President | 1,500 0.0062% | $7.30 | $10,945 | +9.94% | ||
| 2025-05-14 | Heshmatpour Amir F | President | 1,000 0.0041% | $7.27 | $7,267 | +7.71% | ||
| 2025-05-13 | Heshmatpour Amir F | President | 990 0.0039% | $7.01 | $6,942 | +8.01% | ||
| 2025-05-13 | GARNETT KEITHLY | CFO | 90 0.0004% | $7.01 | $631 | +8.01% | ||
| 2025-05-12 | Heshmatpour Amir F | President | 1,400 0.0057% | $7.23 | $10,124 | +30.07% | ||
| 2025-05-12 | CHEN THOMAS C | CEO | 400 0.0016% | $7.00 | $2,800 | +30.07% | ||
| 2025-05-12 | Delshad Jim | director | 5,000 0.0204% | $7.22 | $36,110 | +30.07% | ||
| 2025-05-11 | Heshmatpour Amir F | President | 1,600 0.0068% | $7.51 | $12,016 | +21.32% | ||
| 2025-04-17 | Delshad Jim | director | 50 0.0002% | $6.92 | $346 | +14.82% | ||
| 2025-03-26 | Sale | CHIANG MING-FU (ALAN) | director | 57,696 0.8095% | $24.85 | $1.43M | -19.78% | |
| 2025-03-26 | Sale | CHEN THOMAS C | CEO | 39,233 0.5505% | $24.85 | $975,055 | -19.78% |
| Heshmatpour Amir F | President | 2992000 10.3869% | $9.19M | 9 | 1 | +13.45% |
| Neman-Ebrahim Yousha | Chief Clinical Officer | 134260 0.4661% | $412,178.20 | 1 | 0 | |
| CHEN THOMAS C | CEO | 551668 1.9152% | $1.69M | 3 | 1 | +16.51% |
| GARNETT KEITHLY | CFO | 240900 0.8363% | $739,563.00 | 3 | 1 | +7.91% |
| Delshad Jim | director | 55310 0.192% | $169,801.70 | 3 | 0 | +22.44% |
$9,405,928 | 107 | 12.61% | $74.85M | |
$1,701,941 | 56 | 17.58% | $93.09M | |
$66,137,559 | 49 | 6.29% | $89.66M | |
$77,146,704 | 43 | 13.28% | $93.12M | |
$26,786,140 | 22 | -18.62% | $78.7M |
| Increased Positions | 17 | +106.25% | 381,811 | +21.28% |
| Decreased Positions | 6 | -37.5% | 44,923 | -2.5% |
| New Positions | 8 | New | 111,451 | New |
| Sold Out Positions | 3 | Sold Out | 22,070 | Sold Out |
| Total Postitions | 27 | +68.75% | 2M | +18.78% |